Keenly-watched COVID-19 vaccine 'won't be expensive', developer says

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. KNX
10. QGEN

Go back to Keenly-watched COVID-19 vaccine 'won't be expensive', developer says

Moderna (MRNA) Prices 17.6M Share Common Offering at $76/Sh

May 19, 2020 5:47 AM EDT

Moderna, Inc. (NASDAQ: MRNA) today announced the pricing of an underwritten public offering of 17,600,000 shares of common stock at a public offering price of $76.00 per share, before underwriting discounts and commissions. In addition, Moderna has granted the underwriters a 30-day option to purchase up to... More

Mizuho Securities Reiterates Buy Rating on Pfizer (PFE) After Speaking with Management

May 18, 2020 7:01 AM EDT

Mizuho Securities analyst Vamil Divan reiterated a Buy rating and $42.00 price target on Pfizer (NYSE: PFE) following a conference call with management. Pfizer released updated data on their Duchenne Muscular Dystrophy (DMD) candidate at ASGCT.

Divan's overall conclusion is unchanged in that the... More